After a heart attack, it is important to lower cholesterol levels to prevent future heart attacks. Monitoring cholesterol levels on treatment is just as important as monitoring blood pressure levels on treatment to make sure that the medicines are having the desired effect.

In this interview, C. Noel Bairey Merz, MD, FACC, and Vera Bittner, MD, MSPH, FACC, discuss Low-Density Lipoprotein Cholesterol Testing Following MI Hospitalization Among Medicare Beneficiaries.

Related References:

1. Colantonio, L. D., Wang, Z., Jones, J., Dhalwani, N., Shannon, E. D., Liu, C. Y., Kalich, B., Muntner, P., Rosenson, R. S., & Bittner, V. (2024). Low-Density lipoprotein cholesterol testing following myocardial infarction hospitalization among Medicare beneficiaries. JACC, 3(1), 100753. https://doi.org/10.1016/j.jacadv.2023.100753
2. Ballantyne, C. M., & Agarwala, A. (2024). Reinstating LDL-C measurement as a quality metric. JACC, 3(1), 100749. https://doi.org/10.1016/j.jacadv.2023.100749